IP Library Granted Patent US 8,440,704
Granted Patent B2
US 8,440,704 · App. 12/639,212 · Granted May 14, 2013

Quercetin-containing compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,704
App. No.
12/639,212
Granted
May 14, 2013
Kind
B2
Abstract

This invention relates to a composition containing quercetin, vitamin B3, and vitamin C. Also disclosed is a method of using the composition for enhancing physical or mental performance or treating various diseases or disorders.

Claims (7)

1. A method for treating a disease, lowering cholesterol level or blood pressure, or enhancing mental performance, comprising administering to a subject in need thereof an effective amount of a composition containing quercetin, vitamin B3, and vitamin C as the only active ingredients, a weight ratio between the quercetin, the vitamin B3, and the vitamin C being 1:0.02-1:0.2-2.5; wherein the disease is multiple sclerosis, thyroiditis, myositis, lupus, celiac disease, eczema, urticaria, psoriasis, prostatitis, inflammatory bowel disease, arthritis, leukemia, colon cancer, prostate cancer, kidney cancer, liver cancer, breast cancer, lung cancer, sexual dysfunction, chronic constipation, coronary heart disease, atherosclerosis, stroke, or peripheral arterial disease.

2. The method of claim 1 , wherein the weight ratio is 1:0.04:1.

3. The method of claim 1 , wherein the weight ratio is 1:0.08:1.

4. The method of claim 1 , wherein the composition is a food product selected from the group consisting of tea, soft drink, juice, milk, coffee, jelly, ice cream, yogurt, cookie, cereal, chocolate, and snack bar.

5. The method of claim 1 , wherein the composition is a dietary supplement or a pharmaceutical formulation.

6. The method of claim 1 , wherein the vitamin B3 is niacinamide or nicotinic acid.

7. The method of claim 1 , wherein the disease is coronary heart disease and the vitamin B3 is niacinamide or nicotinic acid.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: QUERCEGEN PHARMA A.G.
To: LINES, THOMAS CHRISTIAN
Reel/Frame 052151/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: LINES, THOMAS CHRISTIAN
To: QUERCIS PHARMA A.G.
Reel/Frame 052153/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2020
From: LINES, THOMAS; QUERCEGEN PHARMA LLC; QUERCEGEN PHARMA LLP; QUERCEGEN TECHNOLOGIES; QUERCEGEN PHARMACEUTICALS, LLC; QUERCEGEN HOLDINGS, LLC; NEW SUN NUTRITION, LLC; THE FRS COMPANY
To: QUERCEGEN PHARMA, AG.
Reel/Frame 052110/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2012
From: QUERCEGEN PHARMA LLC
To: QUERCEGEN PHARMACEUTICALS LLC
Reel/Frame 028677/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2010
From: LINES, THOMAS CHRISTIAN
To: QUERCEGEN PHARMA LLC
Reel/Frame 024021/0192 →